Clinical Trials
8
Active:0
Completed:7
Trial Phases
2 Phases
Phase 1:7
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Phase 1
7 (87.5%)Phase 2
1 (12.5%)Pharmacokinetics and Pharmacodynamics Study of LBS-008 in Healthy Volunteers Aged 50-85
Phase 1
Completed
- Conditions
- Healthy VolunteerDry Age-related Macular Degeneration
- Interventions
- First Posted Date
- 2022-12-28
- Last Posted Date
- 2023-02-23
- Lead Sponsor
- RBP4 Pty Ltd
- Target Recruit Count
- 15
- Registration Number
- NCT05667688
- Locations
- 🇦🇺
Nucleus Network, Melbourne, Australia
This is a Dose-finding Study Followed by 2-year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt Disease
- First Posted Date
- 2022-03-04
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- RBP4 Pty Ltd
- Target Recruit Count
- 13
- Registration Number
- NCT05266014
- Locations
- 🇦🇺
Sydney Children's Hospitals Network, Westmead, New South Wales, Australia
🇦🇺Lions Eye Institute, Perth, Western Australia, Australia
🇨🇳National Taiwan University Hospital, Taipei, Taiwan
Safety and Tolerability Study of LBS-008 in Healthy Adult Subjects After Single and Multiple Doses
- First Posted Date
- 2018-11-08
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- RBP4 Pty Ltd
- Target Recruit Count
- 71
- Registration Number
- NCT03735810
- Locations
- 🇦🇺
Linear Clinical Research, Perth, Australia
News
No news found